{
    "Trade/Device Name(s)": [
        "NucliSENS EasyQ\u00ae MRSA Assay",
        "NucliSENS EasyQ\u00ae MRSA Instrumentation and Software",
        "NucliSENS EasyQ\u00ae MRSA assay protocol software"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K102740",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033415",
        "K093383"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX",
        "OOI"
    ],
    "Summary Letter Date": "May 10, 2011",
    "Summary Letter Received Date": "May 12, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)",
        "SCCmec cassette junction",
        "mecA gene"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "Sterile dry flocked swab with transport tube"
    ],
    "Instrument(s)/Platform(s)": [
        "NucliSENS EasyQ\u00ae Analyzer",
        "NucliSENS EasyQ\u00ae Incubator",
        "NucliSENS EasyQ\u00ae Director Software 2.6",
        "Vortex Genie 2 with MOBlO adaptor"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid sequence-based amplification (NASBA)",
        "Molecular beacon fluorescent probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Isothermal amplification",
        "Sequence-specific molecular beacon detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Software",
        "Kit",
        "Reagent",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for NucliSENS EasyQ MRSA qualitative assay using NASBA and molecular beacon detection of MRSA DNA from nasal swabs",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for direct detection of MRSA from nasal swabs in patients at risk for nasal colonization, used as a screening tool to aid prevention and control of MRSA infections in health care institutions; not for diagnosing, guiding, or monitoring treatment.",
    "fda_folder": "Microbiology"
}